Quick Answer
Celldex Therapeutics, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $1.55 million for the year ending 2025.
- Celldex Therapeutics, Inc. showed a decrease of -78.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Celldex Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), Celldex Therapeutics, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 77.2%.
- Historical annual values: Fiscal year 2025: $1.55 million | Fiscal year 2024: $7.02 million | Fiscal year 2023: $6.88 million | Fiscal year 2022: $2.36 million | Fiscal year 2021: $4.65 million | Fiscal year 2020: $7.42 million | Fiscal year 2019: $3.57 million | Fiscal year 2018: $9.54 million | Fiscal year 2017: $12.74 million | Fiscal year 2016: $6.79 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: